Dr. Freeman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 15th St
Suite 310
Greeley, CO 80631
Summary
- Dr. Scott Freeman is an interventional cardiologist in Northern Colorado with Banner NCMC. He received his medical degree from Virginia Commonwealth University and completed his internal medicine training at the University of Colorado, where he was Chief Resident. He then completed Cardiology, Interventional Cardiology, and Structural Heart disease training at the University of Colorado.
Education & Training
- University of ColoradoFellowship, Interventional Cardiology, 2022 - 2024
- University of ColoradoFellowship, Cardiovascular Disease, 2019 - 2022
- University of ColoradoChief Residency, Internal Medicine, 2018 - 2019
- University of ColoradoResidency, Internal Medicine, 2016 - 2018
- University of ColoradoInternship, Internal Medicine, 2015 - 2016
- Virginia Commonwealth University School of MedicineClass of 2015
Certifications & Licensure
- CO State Medical License 2018 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Gold Humanism Honor Society Arnold P. Gold Foundation, 2016
Publications & Presentations
PubMed
- 4 citationsInteraction of COVID-19 With Common Cardiovascular Disorders.Peter K Boulos, Scott V Freeman, Timothy D Henry, Ehtisham Mahmud, John C Messenger
Circulation Research. 2023-05-12 - 74 citationsSprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPARγ in Non–Small Cell Lu...Meredith A. Tennis, Michelle Van Scoyk, Scott V. Freeman, Katherine M. Vandervest, Raphael A. Nemenoff
Molecular Cancer Research. 2010-06-01 - 41 citationsProstacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.Meredith A. Tennis, Michelle Van Scoyk, Lynn E. Heasley, Katherine M. Vandervest, Mary C.M. Weiser-Evans
Neoplasia. 2010-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: